Failed AstraZeneca cancer drug provides hope for Alzheimer's
This article was originally published in Scrip
Executive Summary
A drug that AstraZeneca had pursued as a treatment for cancer – only to see it fail in mid-stage development – has provided new hope as a potential therapy for Alzheimer's disease, Yale University researchers, supported by a program from the National Institutes of Health (NIH), reported.